MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Multimodal Information Exploration for Automated Clinical Scale Prediction in Neurodegenerative Diseases

    N. Bozetine, M. Wójcik-Pędziwiatr, M. Baran, J. Stępień, J. Krzywdziak, W. Szecówka, M. żbik, M. Dudek, J. Sikora, D. Hemmerling, M. Rudzińska-Bar (Warsow, Poland)

    Objective: The primary objective of this study was to develop and evaluate machine learning methods for the automatic prediction of standardized clinical scales using multimodal…
  • 2026 International Congress

    Racial Disparities in End-of-Life Care among Patients with Advanced Movement Disorders in an Interdisciplinary Supportive Care Clinic

    K. Sugiura, M. Tharp, M. Husain, A. Hong, Y. Chen, A. Naveed, D. Shankar, K. Gustashaw, S. Chen, G. Hong, J. Fleisher, N. Kramer (Chicago, USA)

    Objective: To examine whether an interdisciplinary supportive care clinic model mitigates racial disparities in advance care planning (ACP), hospice utilization, and place of death among…
  • 2026 International Congress

    Integrative Analysis of GBA1 Mutations and GCase Deficiency in Parkinson’s Disease using Long Read Nanopore Sequencing

    A. Shaikh, S. Prakash, R. Valmiki (Vellore, India)

    Objective: To sequence the GBA1 gene in PD patients with reduced GCase activity using nanopore amplicon-targeted sequencing.To characterize benign, VUS, and pathogenic GBA1 variants. Background:…
  • 2026 International Congress

    Can a slogan poster featuring the patient’s primary physician help improve gait and prevent falls at home in patients with Parkinson’s disease?

    Y. Okuma (Izunokuni, Japan)

    Objective: To present cases with Parkinson’s disease (PD) suggesting that a slogan poster aimed at improving gait and preventing falls may be effective. Background: Patients…
  • 2026 International Congress

    Effects of Auricular Vagus Nerve Stimulation Combined with Neurorehabilitation on Motor Symptoms, Balance, and Gait in People with Parkinson’s Disease: Preliminary Results of a Prospective Study

    M. Salamci, A. Guclu-Gunduz, M. Akbostanci (Ankara, Turkey)

    Objective: This study aimed to examine the effects of auricular vagus nerve stimulation (aVNS) combined with neurorehabilitation on motor symptoms, balance, and gait in people…
  • 2026 International Congress

    Fracture Burden and Health-Related Quality of Life in Older Adults with Parkinson’s Disease in Rural India: A Community-Based Study

    B. Kuanar, D. Panda (Bhubaneswar, India)

    Objective: This study aimed to examine the relationship between fracture history and health-related quality of life (HRQoL) among elderly individuals with Parkinson’s disease residing in…
  • 2026 International Congress

    Patient perspectives on meaningful symptoms and disease progression in Parkinson’s Disease (PD): Interim findings from the Patient Endpoint Preference Project (PEPP)

    V. Di Foggia, A. Noyce, E. Shelton, J. Mammen, F. de Renzis, A. Hursey, N. Wickramasekera, D. Rowen, M. Wilson, D. Magalhaes, J. Holenz, G. Harrison-Jones (Coronado, Portugal)

    Objective: The Patient Endpoint Preference Project (PEPP) aims to identify and quantify early‑stage PD patients’ priorities around symptoms and their progression using patient‑reported questionnaires. The…
  • 2026 International Congress

    Translational evaluation of CSF as a relevant compartment for assessing target engagement of therapeutic anti–α-syn antibodies.

    M. Ramos Vega, B. Ozgur, F. Sotty, A. Jensen, K. Bjerregaard-Andersen (Copenhagen, Denmark)

    Objective: To evaluate a translational free/total α-synuclein (α-syn) assay framework to quantify in vivo target engagement (TE) of anti–α-syn antibodies in preclinical models and to…
  • 2026 International Congress

    Subtype-specific alterations of iron deposition and neuromelanin loss in the substantia nigra of Parkinson’s disease

    A. Shima, Y. Sakato, R. Sakai, Y. Terada, D. Kambe, A. Nishida, K. Yoshimura, H. Sakamaki, I. Wada, M. Sawamura, E. Nakanishi, H. Yamakado, S. Okuchi, T. Okada, Y. Fushimi, Y. Nakamoto, R. Takahashi, R. Matsumoto, N. Sawamoto (Kyoto, Japan)

    Objective: To investigate the specific pathological changes in the substantia nigra (SN) across  Parkinson’s disease (PD) subtypes, focusing on iron deposition and NM depletion both…
  • 2026 International Congress

    Limited Evidence for TPBG Variants in Parkinson’s Disease Risk Across Global Ancestries

    R. Laban, R-A. Steopoaie, C. Herghelegiu, N. Ioana, I. Salazar, A. López Lobato, B. Popescu, A. Noyce, M. Periñan, P. Reyes, A. Zirra (London, United Kingdom)

    Objective: To evaluate ancestry-specific associations between common TPBG variants and Parkinson’s disease (PD) risk in the Global Parkinson’s Genetic Program (GP2). Background: The trophoblastic glycoprotein…
  • « Previous Page
  • 1
  • …
  • 152
  • 153
  • 154
  • 155
  • 156
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley